---
figid: PMC9245155__nihms-1801163-f0002
pmcid: PMC9245155
image_filename: nihms-1801163-f0002.jpg
figure_link: /pmc/articles/PMC9245155/figure/F2/
number: Figure 2
figure_title: ''
caption: Binding of BRAF inhibitors and MEK inhibitors creates blockade points in
  the MAPK pathway, inhibiting oncogenic signaling (i.e., reduced gene transcription,
  reduced cell growth and proliferation).
article_title: 'Cancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and
  Ocular Autoimmunity.'
citation: Aditya Rali, et al. Int Ophthalmol Clin. ;62(3):49-63.
year: '2023'

doi: 10.1097/IIO.0000000000000434
journal_title: International ophthalmology clinics
journal_nlm_ta: Int Ophthalmol Clin
publisher_name: ''

keywords:
- checkpoint inhibitor
- targeted therapy
- immune-related adverse events
- VKH-like syndrome
- uveitis

---
